Skip to content
CheckOrphan
  • Home
  • About Us
  • Team
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • All Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Access Program
  4. /
  5. Kite Pharma, Inc. –...

Kite Pharma, Inc. – Relapsed/Refractory High-Grade B-Cell Lymphoma

Submitted By:
Published Date:
January 25, 2020

Access Program Information

A multicenter, open-label expanded access protocol for the treatment of subjects with
relapsed/refractory large B-cell lymphoma.

Rare Disease:
Spondyloepiphyseal dysplasia congenita Spondyloepiphyseal dysplasia- congenita
Free Newsletter

Tools

Subscribe to our newsletter

Email Alerts

Rss Feeds

Print this page

Follow us on:

News

  • FDA Approves Blueprint Medicines’ AYVAKIT™ (avapritinib) for t
  • Geron Announces Publication of IMbark Phase 2 Data in Journal of Clini
  • Eisai and Bristol Myers Squibb Enter Into Global Strategic Collaborati
More News

Events

  • 2nd International Primary Immunodeficiencies Congress (IPIC)
  • 11th International Congress on Systemic Lupus Erythematosus
  • Glycoproteinoses: Fourth International Conference on Advances in Patho
  • 7th International Conference on Children’s Bone Health
More Events
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2021 CheckOrphan.
    Developed by: Gonza.io logo Powered by: Cloudscale logo